ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding ProQR Therapeutics N.V. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 65 | 62 | −3 |
| Shares | 41.3M | 40.5M | −835.6K (−2.0%) |
| Value | $54.9M | $82.4M | +$27.5M (+50.0%) |
New holders (4)
Institutions that held ProQR Therapeutics N.V. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 868,069 | $1.77M | 0.59% |
| HRT Financial LP | 12,297 | $25.0K | 0.00% |
| Engineers Gate Manager LP | 10,730 | $21.9K | 0.00% |
| Group One Trading, L.P. | 3,541 | $7.22K | 0.00% |
Sold out (7)
Institutions that held ProQR Therapeutics N.V. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Squarepoint Ops LLC | 112,463 | $149.6K |
| American Century Companies Inc | 77,686 | $103.3K |
| Quadrature Capital Ltd | 26,403 | $35.4K |
| Invesco Ltd. | 18,084 | $24.1K |
| XTX Topco Ltd | 16,079 | $21.4K |
| Gsa Capital Partners LLP | 14,683 | $20.0K |
| Flaharty Asset Management, LLC | 2,000 | $2.66K |